| scholarly article | Q13442814 |
| P2093 | author name string | Xiao Dong | |
| Yan Cai | |||
| Bai-Ren Wang | |||
| Hong-Liang Liang | |||
| Hui-Yuan Hou | |||
| Yu-Sheng Wang | |||
| Yuan-Yuan Shi | |||
| Zhao-Xia Zhang | |||
| P2860 | cites work | Multilineage potential of adult human mesenchymal stem cells | Q27860737 |
| Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization | Q28203561 | ||
| Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy | Q28257133 | ||
| Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor | Q28267797 | ||
| Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors | Q64378688 | ||
| Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor | Q64378703 | ||
| Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents | Q64379193 | ||
| The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization | Q80376104 | ||
| Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions | Q28291480 | ||
| Marrow stromal cells as stem cells for nonhematopoietic tissues | Q29618770 | ||
| The Role of Adult Bone Marrow-Derived Stem Cells in Choroidal Neovascularization | Q31017364 | ||
| Bone Marrow-Derived Progenitor Cells Contribute to Experimental Choroidal Neovascularization | Q31017378 | ||
| Choroidal neovascularization is provided by bone marrow cells | Q31033882 | ||
| AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization | Q31064406 | ||
| Stimulation of neovascularization by the anti-angiogenic factor PEDF. | Q31131108 | ||
| Quantitative enumeration of vascular smooth muscle cells and endothelial cells derived from bone marrow precursors in experimental choroidal neovascularization | Q31148438 | ||
| Nicotine promotes contribution of bone marrow-derived cells to experimental choroidal neovascularization in mice. | Q33333761 | ||
| Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies | Q35126780 | ||
| Human mesenchymal stem cells in contact with their environment: surface characteristics and the integrin system | Q35458958 | ||
| Choroidal neovascularization: a wound healing perspective. | Q35634483 | ||
| Choroidal neovascularization | Q35688110 | ||
| Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential. | Q35859456 | ||
| Focus on Molecules: Pigment epithelium-derived factor (PEDF). | Q36346539 | ||
| Rationale for combination therapies for choroidal neovascularization | Q36357401 | ||
| The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles | Q36842444 | ||
| Retinal and choroidal microangiopathies: therapeutic opportunities. | Q36856719 | ||
| Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts | Q36888428 | ||
| Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles | Q36901346 | ||
| Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors | Q36990691 | ||
| Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration | Q37064822 | ||
| Cell and gene therapy using mesenchymal stem cells (MSCs). | Q37076762 | ||
| The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration | Q37214144 | ||
| Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model | Q37310677 | ||
| PEDF from mouse mesenchymal stem cell secretome attracts fibroblasts | Q40001215 | ||
| The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury | Q40025597 | ||
| Pigment epithelium-derived factor in the monkey retinal pigment epithelium and interphotoreceptor matrix: apical secretion and distribution. | Q42455706 | ||
| Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. | Q42492807 | ||
| Role of apoptosis in the cytotoxic effect mediated by daunorubicin in cultured human retinal pigment epithelial cells | Q44131970 | ||
| Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model. | Q44470878 | ||
| Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation | Q46567786 | ||
| Contribution of bone-marrow-derived cells to choroidal neovascularization | Q47284966 | ||
| Recruitment of marrow-derived endothelial cells to experimental choroidal neovascularization by local expression of vascular endothelial growth factor | Q47697234 | ||
| The interactions between brain microvascular endothelial cells and mesenchymal stem cells under hypoxic conditions | Q48091565 | ||
| Potential risks of bone marrow cell transplantation into infarcted hearts. | Q50685139 | ||
| The dynamic conduct of bone marrow-derived cells in the choroidal neovascularization microenvironment. | Q50704707 | ||
| Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents | Q58828469 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neovascularization | Q1281049 |
| mesenchymal stem cell | Q1922379 | ||
| P304 | page(s) | 1837-1845 | |
| P577 | publication date | 2010-07-20 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | A therapeutic strategy for choroidal neovascularization based on recruitment of mesenchymal stem cells to the sites of lesions | |
| P478 | volume | 18 |
| Q47136957 | Advanced glycation end products promote VEGF expression and thus choroidal neovascularization via Cyr61-PI3K/AKT signaling pathway |
| Q26765959 | Bone marrow-derived cells in ocular neovascularization: contribution and mechanisms |
| Q41572871 | Cellular Reparative Mechanisms of Mesenchymal Stem Cells for Retinal Diseases |
| Q36819400 | Great promise of tissue-resident adult stem/progenitor cells in transplantation and cancer therapies |
| Q28484492 | Hyperglycaemia exacerbates choroidal neovascularisation in mice via the oxidative stress-induced activation of STAT3 signalling in RPE cells |
| Q46165770 | In vivo bioluminescence imaging monitoring of stem cells' participation in choroidal neovascularization |
| Q36013023 | In vivo bioluminescence imaging of hyperglycemia exacerbating stem cells on choroidal neovascularization in mice |
| Q36909590 | Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury |
| Q33883649 | Influence of Dll4 via HIF-1α-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions. |
| Q36691521 | Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice |
| Q37801377 | Mesenchymal Stem Cells and Potential Applications in Treating Ocular Disease |
| Q35924341 | Mesenchymal stem cells for retinal diseases |
| Q35962115 | MicroRNA-195a-3p inhibits angiogenesis by targeting Mmp2 in murine mesenchymal stem cells |
| Q33927575 | Monocyte/macrophages promote vasculogenesis in choroidal neovascularization in mice by stimulating SDF-1 expression in RPE cells |
| Q91792402 | Ocular progenitor cells and current applications in regenerative medicines - Review |
| Q38014713 | Ophthalmic transplantology: posterior segment of the eye--part II |
| Q95293192 | Pigment Epithelium-derived factor (PEDF) and PEDF-Receptor in the adult mouse brain: Differential spatial/temporal localization pattern |
| Q28544711 | Polysaccharide hydrogel combined with mesenchymal stem cells promotes the healing of corneal alkali burn in rats |
| Q38855251 | Revisiting the role of erythropoietin for treatment of ocular disorders. |
| Q89888023 | Risk factors for progression of age-related macular degeneration |
| Q36000069 | Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization |
| Q26746974 | Stem Cell Therapy for Treatment of Ocular Disorders |
| Q37972176 | Stem cell therapy for retinal diseases: update |
| Q50472015 | Stromal cell-derived factor 1α-stimulated mesenchymal stem cells confer enhanced protection against light-induced retinal degeneration in rats. |
| Q37863677 | Surgical approaches to gene and stem cell therapy for retinal disease |
| Q38016850 | The emerging role of PEDF in stem cell biology |
| Q92450510 | Therapeutic effect against retinal neovascularization in a mouse model of oxygen-induced retinopathy: bone marrow-derived mesenchymal stem cells versus Conbercept |
Search more.